emocha Mobile Health
Online platform to track dose-by-dose medication
emocha is an online platform and app to track patient’s dose-by-dose medication using video Directly Observed Therapy (DOT)
Implementing organizations and partners:
- Maryland Innovation Initiative
- BioHealth Innovation
- Kapor Capital
- NIH – National Institute of Drug Abuse
- NIH – National Institute on Minority Health and Health Disparities
- SBIR – STTR
Free app downoad in Google Play
Goal 3: Ensure healthy lives and promote well-being for all at all ages
- Patients in need of medication
- Researchers running clinical trials
- Public Health Departments
500+ app installs according to Google Play
Connectivity requirement for the product/service to work (mobile internet, SMS, voice, fixed internet, Wi-Fi, other [specify]).
Coverage required for the product/service to work (2G, 3G, 4G, LTE, broadband, dial-up, other [specify]).
Device features required for the product/service to work (bluetooth, Wi-Fi, camera, IVR, GPS, accelerometers/motion sensors, physiologic biosensors, biometric identifiers, SIM, memory card (e.g microSD), other [specify]).
Device(s) type required for the product/service to work (smartphone, feature phone, computer, tablet, other [specify]).
Connectivity requirement for the product/service to work. Some apps/services can work offline. If no, specify if network connectivity is needed at any point (e.g connectivity needed for download).
Is the product/service able to receive and send back information to the user?
Rates of user vs downloads/subscriptions – Compliance rate for the eHealth service
Support according to the literacy level required from the user. If yes, specify type of literacy support. If no, the user is intended to be literate.
Operating system required and software version (Android, IOs, Windows, other [specify])
Power supply required for the product/service to work (uninterrupted prower supply (UPS), ocassional power supply [minimum time required], other).
Education and behavior change, human resource management, decision support, data collection & analytics, electronic medical records, Healthcare provider- CHW training, telemedicine/remote diagnostic, stock management, disease surveillance and reporting
miDOT is a smartphone application that allows patients to indicate symptoms and record themselves taking their medication. The patient can then securely submit this information to the emocha server, where a clinician can then observe and confirm medication adherence using the emocha web interface. The system also includes a notifications feature to remind patients to take their medication and inform providers about important patient-reported events.
- Dose-by-dose tracking using video Directly Observed Therapy (DOT)
- Patient-doctor communication
Provided by the manufacturer
Dose by Dose Adherence: patients use the mobile application to record videos of themselves taking their medication. This creates accountability and encourages communication with providers when needed. Providers benefit from dose-by-dose adherence data to better serve patient needs.
Amplify Patient Engagement: the secure mobile communication tools integrated into the platform, allow to send patients notes of encouragement or check in when they miss their medication.
Focus Resources: smart filtering to help patients struggling with adherence, experiencing side effects, or reporting cravings for opioid use disorder.
Reduce costs and improve outcomes: reduced hospitals readmissions, health plans savings on downstream expenditures, DOT programs cut down on daily transportation time. Improvement on patient health due to the medication being taken properly.
miDOT supports a minimum of 200 patients and 10 clinicians simultaneously. Emocha estimates that miDOT will save each of the 98 counties in the U.S with the highest number of TB cases an average of $40,000 per year.
miDOT has already been implemented in Harris County (TX) and Baltimore (MD). Data is actively being gathered on usability, patient adherence, and cost savings at four Maryland health departments with support from an NIH grant. miDOT is also being used in an adherence-related study of Hepatitis C Virus in Denver, CO. miDOT will soon be tested in Pune and Bangalore, India.
In a National Institute of Minority Health and Health Disparities Small Business Innovation Research grant across 3 Maryland public health departments, 100% of patients successfully completed tuberculosis treatment.
Public health departments and academic medical centers have evaluated emocha with support from the National Institute on Minority Health and Health Disparities, the National Institute on Drug Abuse, and the Patient Centered Outcomes Research Institute.
HIPAA-secure mobile communications
- Hatef, Elham, Sharfstein, Joshua M., Labrique, Alain B. (2018): Innovation and Entrepreneurship: Harnessing the Public Health Skill Set in a New Era of Health Reforms and Investment. Journal of Public Health Management and Practice, 2, 99-101.
- Bollinger, Robert C. et al. Building a Global Health Education Network for Clinical Care and Research. The Benefits and Challenges of Distance Learning Tools. Lessons Learned from the Hopkins Center for Clinical Global Health Education. Infectious Disease Clinics , Volume 25 , Issue 2 , 385 – 398.
- Veronica Njie-Carr, Sheila Kalengé, Jack Kelley, Amy Wilson, Joshua Kanaabi Muliira, Rose Chalo Nabirye, Nancy Glass, Robert Bollinger, Stella Alamo-Talisuna, Larry William Chang. Research Capacity–Building Program for Clinicians and Staff at a Community-Based HIV Clinic in Uganda: A Pre/Post Evaluation. Journal of the Association of Nurses in AIDS Care, Volume 23, Issue 5, 2012, Pages 431-441, ISSN 1055-3290
- Hoffman, J. A., Cunningham, J.R., Suleh, A.J., Sundsmo, A., Dekker, D., Vago, F., Munly, K., Igonya, E. K., Hunt-Glassman, J. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med. 2010 Jul; 39(1):78-80.
Solution tested by partner oraganizations:
- Pathway Healthcare case studies for opioid use disorder
- Harris County, Texas has used emocha for active and latent TB treatment with over 400 patients since 2014
- Massachusetts General Hospital case studies for HCV treatment
- Baltimore City, Philadelphia, and Washington, D.C. case studies for HIV and PrEP treatments
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.